ValuEngine downgraded shares of Petmed Express (NASDAQ:PETS) from a buy rating to a hold rating in a research report released on Friday.
A number of other research firms have also recently commented on PETS. BidaskClub raised Petmed Express from a buy rating to a strong-buy rating in a report on Saturday, December 9th. Northcoast Research set a $58.00 price objective on Petmed Express and gave the stock a buy rating in a report on Wednesday, January 3rd. Finally, Noble Financial reaffirmed a hold rating on shares of Petmed Express in a report on Friday, October 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus price target of $42.80.
Shares of Petmed Express (NASDAQ PETS) traded up $1.97 during trading hours on Friday, hitting $47.20. The company had a trading volume of 455,189 shares, compared to its average volume of 855,916. The company has a market cap of $1,010.00, a P/E ratio of 26.22, a PEG ratio of 2.57 and a beta of 0.95. Petmed Express has a 52 week low of $19.21 and a 52 week high of $57.80.
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 16th. Stockholders of record on Monday, February 5th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 2.12%. This is a boost from Petmed Express’s previous quarterly dividend of $0.20. The ex-dividend date was Friday, February 2nd. Petmed Express’s dividend payout ratio is 55.56%.
In related news, Director Ronald J. Korn sold 5,000 shares of the stock in a transaction on Monday, January 29th. The stock was sold at an average price of $48.38, for a total transaction of $241,900.00. Following the sale, the director now owns 68,833 shares in the company, valued at approximately $3,330,140.54. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gian Fulgoni sold 20,000 shares of the stock in a transaction on Friday, December 15th. The shares were sold at an average price of $44.38, for a total value of $887,600.00. Following the sale, the director now owns 55,900 shares in the company, valued at approximately $2,480,842. The disclosure for this sale can be found here. Insiders have sold a total of 65,000 shares of company stock worth $3,229,500 over the last ninety days. Insiders own 4.00% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. Elkfork Partners LLC purchased a new stake in Petmed Express during the 4th quarter valued at $100,000. LS Investment Advisors LLC raised its holdings in Petmed Express by 283.5% during the 4th quarter. LS Investment Advisors LLC now owns 2,861 shares of the company’s stock valued at $130,000 after buying an additional 2,115 shares during the period. Sterling Investment Advisors Ltd. raised its holdings in Petmed Express by 118.5% during the 4th quarter. Sterling Investment Advisors Ltd. now owns 2,950 shares of the company’s stock valued at $134,000 after buying an additional 1,600 shares during the period. Sei Investments Co. raised its holdings in Petmed Express by 50,142.9% during the 3rd quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock valued at $117,000 after buying an additional 3,510 shares during the period. Finally, CenterStar Asset Management LLC purchased a new stake in Petmed Express during the 4th quarter valued at $169,000. Institutional investors own 92.01% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This story was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.com-unik.info/2018/02/24/valuengine-lowers-petmed-express-pets-to-hold.html.
About Petmed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.